Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Angela A. Anthony"'
Autor:
Thamal Darshana, Dayananda Bandara, Upul Nawarathne, Udaya de Silva, Yasinta Costa, Kalavitigoda Pushpakumara, Sumithra Pathirage, Seuwandi Basnayake, Chamila Epa, Pradeepa Dilrukshi, Maheshaka Wijayawardena, Angela A. Anthony, Rexan Rodrigo, Aresha Manamperi, Frances Smith, Angela Allen, Stephan Menzel, David Rees, Anuja Premawardhena
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-9 (2020)
Abstract Background Though case reports and limited case series of Sickle cell disease in Sri Lanka have been reported previously, no attempt has been made hitherto to undertake a comprehensive genotypic-phenotypic analysis of this “rare” group o
Externí odkaz:
https://doaj.org/article/235f38c87dfa4b928d192bd1a390279a
Autor:
Kam, Kyung-Yoon, Jalin, Angela M. Anthony, Choi, Yong Won, Kaengkan, Phatcharida, Park, Sung Woo, Kim, Young Hoon, Kang, Sung Goo
Publikováno v:
In Progress in Neuropsychopharmacology & Biological Psychiatry 1 October 2012 39(1):69-74
Autor:
Dayananda Bandara, Kalavitigoda Pushpakumara, Frances Smith, Udaya de Silva, Stephan Menzel, A. Manamperi, Pradeepa Dilrukshi, Maheshaka Wijayawardena, Anuja Premawardhena, Thamal Darshana, Rexan Rodrigo, Sumithra Pathirage, Angela A. Anthony, Upul Nawarathne, Seuwandi Basnayake, David C. Rees, Chamila Epa, Angela Allen, Yasinta Costa
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-9 (2020)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases
Background Though case reports and limited case series of Sickle cell disease in Sri Lanka have been reported previously, no attempt has been made hitherto to undertake a comprehensive genotypic-phenotypic analysis of this “rare” group of patient
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hwa Young Song, Jee-In Chung, Angela Melinda Anthony Jalin, Chung Ju, Kisoo Pahk, Chanmin Joung, Sekwang Lee, Sejong Jin, Byoung Soo Kim, Ki Sung Lee, Jei-Man Ryu, Won-Ki Kim
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 3; Pages: 1403
International Journal of Molecular Sciences, Vol 23, Iss 1403, p 1403 (2022)
International Journal of Molecular Sciences, Vol 23, Iss 1403, p 1403 (2022)
Acute ischemic stroke is the leading cause of morbidity and mortality worldwide. Recombinant tissue plasminogen activator (rtPA) is the only agent clinically approved by FDA for patients with acute ischemic stroke. However, delayed treatment of rtPA
Autor:
Jae-Chul Lee, G. Cho, Kisoo Pahk, Chung Ju, Hwa Young Song, Chunsook Kim, Angela M.A. Anthony Jalin, Won Ki Kim
Publikováno v:
Biomolecules & Therapeutics
Preceding infection or inflammation such as bacterial meningitis has been associated with poor outcomes after stroke. Previously, we reported that intracorpus callosum microinjection of lipopolysaccharides (LPS) strongly accelerated the ischemia/repe
Autor:
Jong Hoon Ryu, Si Ling Wang, Inyoung Choi, Chung Ju, Hee Sun Kim, Woong Sun, Chan Young Shin, G. Cho, Kung Woo Nam, Ying Cai, Won Ki Kim, Angela M.A. Anthony Jalin
Publikováno v:
The Journal of Immunology. 187:1314-1321
In intracerebral hemorrhage, microglia become rapidly activated and remove the deposited blood and cellular debris. To survive in a harmful hemorrhagic or posthemorrhagic condition, activated microglia must be equipped with appropriate self-defensive
Autor:
Yong-Hyun Lee, Jei-Man Ryu, Chung Ju, Il Hwan Cho, Eun-Bang Lee, Byung-Su Kim, Angela M.A. Anthony Jalin, Kim Won Seok, Won-Ki Kim
Publikováno v:
Stroke. 46
In cerebral ischemia, neurons and glia are deteriorated by various mechanisms including excitotoxicity, oxidative stress and inflammatory responses. Thus, pharmacological blockade of multiple cytotoxic pathways would be a therapeutic strategy for the
Autor:
Jin Sun Kwon, Angela M.A. Anthony Jalin, Chung Ju, Maheswari Rajasekaran, Yongseok Choi, Veeraswamy Gajulapati, Kisoo Pahk, Chunsook Kim, Won Ki Kim, Paul L. Prather
Publikováno v:
PLOS ONE(10): 10
PLoS ONE, Vol 10, Iss 10, p e0141600 (2015)
PLoS ONE
PLoS ONE, Vol 10, Iss 10, p e0141600 (2015)
PLoS ONE
Growing evidence suggests that therapeutic strategies to modulate the post-ischemic inflammatory responses are promising approaches to improve stroke outcome. Although the endocannabinoid system has been emerged as an endogenous therapeutic target to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4437ba58e54332c3b0529ce850e630a
http://open-repository.kisti.re.kr/cube/handle/open_repository/482470.do
http://open-repository.kisti.re.kr/cube/handle/open_repository/482470.do
Publikováno v:
The American journal of pathology. 182(3)
The type 2 cannabinoid receptor (CB2R) was recently shown to mediate neuroprotection in ischemic injury. However, the role of CB2Rs in the central nervous system, especially neuronal and glial CB2Rs in the cortex, remains unclear. We, therefore, inve